Harvard Bioscience Earnings Conference Call Scheduled
Harvard Bioscience, Inc. (NASDAQ: HBIO), a leader in life sciences technologies, has scheduled its third-quarter earnings conference call. This event will take place on a specified November morning, marking an opportunity for investors and stakeholders to gain insights into the company's financial performance.
Details on the Upcoming Earnings Call
During this call, the company will present its financial results for the quarter that ended September 30, highlighting significant updates and performances. Investors looking to gain a deeper understanding of the company's trajectory are encouraged to participate in the call at 8:00 a.m. Eastern Time. This session will provide vital financial information as Harvard Bioscience continues to push boundaries in life sciences.
How to Join the Conference Call
Those interested in joining the call and asking questions must complete a registration process to receive unique dialing credentials. It’s a straightforward step that ensures participants are well prepared for an informative session.
Audio-Only Webcast Access
For individuals opting for a more flexible approach, an audio-only webcast option will be made available. This alternative allows participants to tune in without needing to register, fitting seamlessly into their schedules.
Financial Highlights and Company Updates
Participants can expect comprehensive presentations that will include Harvard Bioscience's financial release along with a related slide deck. These materials will be available on the company’s Investor Relations section, enabling stakeholders to follow along and engage deeply with the information being shared.
About Harvard Bioscience
Harvard Bioscience, Inc. embodies a commitment to advancing life sciences through innovative products and technologies. With a diverse clientele encompassing academic institutions, government labs, and top-tier pharmaceuticals, the company is a vital partner in research and development across various fields. Their operational presence spans the United States, Europe, and China, allowing them to cater to a global market effectively.
Mission and Vision
At the core of Harvard Bioscience’s strategies is a focus on fostering significant advancements in pharmaceutical research, bio-production, and testing. Their mission aligns with driving forward-thinking solutions that can enhance both research and therapeutic discoveries.
Contact Information for Inquiries
For inquiries regarding financial performance or investor relations, Jennifer Cote, the Chief Financial Officer, is the main point of contact available at (508) 893-3120. Additionally, for investor communications, Sandy Martin of Three Part Advisors is reachable directly at (214) 616-2207.
Frequently Asked Questions
When is the earnings call scheduled?
The earnings call is scheduled for November, allowing investors to delve into the company's financial results.
How can I participate in the call?
Participants must register to receive unique dialing information, ensuring they can join and engage during the session.
What information will be shared during the earnings call?
The call will cover financial results, operational updates, and potentially strategic insights into future initiatives.
Where can I find more information about Harvard Bioscience?
More details about the company, its products, and recent news can be found on their official website.
Who should I contact for investor relations?
Jennifer Cote and Sandy Martin are designated contacts for inquiries related to financial matters and investor relations.
